News & Analysis on Clinical Trial Services & Contract Research And Development
AstraZeneca has been granted approval for a new drug - the first in its class - for the prevention of blood clotting complications (venous thromboembolism) in major orthopaedic (hip or knee replacement) surgery. It is the first new anticoagulant...
Life sciences technology company Invitrogen has entered into a definitive agreement to acquire fellow US firm BioReliance, which specialises in the testing and manufacture of biologic drugs.
A protein that forms part of the cytoskeleton of cells could be a new target for medicines that prevent the spread of tumour cells around the body, according to new research published on Nature's website.
There are fears that a renewed epidemic of severe acute respiratory syndrome (SARS) could occur in 2004, after initial tests on a patient with symptoms associated with the disease suggested that the causative agent was the SARS coronavirus (CoV).